155 related articles for article (PubMed ID: 33217509)
1. Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020.
Bettuzzi T; Ingen-Housz-Oro S; Purtillo CC; Le Cleach L; Maison P; de Prost N; Wolkenstein P; Lebrun-Vignes B; Sbidian E
J Am Acad Dermatol; 2021 Dec; 85(6):1581-1584. PubMed ID: 33217509
[No Abstract] [Full Text] [Related]
2. Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase.
Bettuzzi T; Ingen-Housz-Oro S; Maison P; de Prost N; Wolkenstein P; Lebrun-Vignes B; Sbidian E
Pharmacoepidemiol Drug Saf; 2022 Apr; 31(4):434-441. PubMed ID: 34907614
[TBL] [Abstract][Full Text] [Related]
3. Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database.
Bettuzzi T; Drucker A; Staumont-Sallé D; Bihan K; Lebrun-Vignes B; Sbidian E
J Am Acad Dermatol; 2022 Feb; 86(2):431-433. PubMed ID: 34600034
[No Abstract] [Full Text] [Related]
4. Association of Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs in pediatric patients: Subgroup analysis based on a Japanese spontaneous database.
Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K; Hosohata K
J Clin Pharm Ther; 2019 Oct; 44(5):775-779. PubMed ID: 31231846
[TBL] [Abstract][Full Text] [Related]
5. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.
Lebrun-Vignes B; Guy C; Jean-Pastor MJ; Gras-Champel V; Zenut M;
Br J Clin Pharmacol; 2018 Feb; 84(2):331-338. PubMed ID: 28963996
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization.
Zheng Y; Zhou W; Guo X; Chi L; Chen C; Guo Z; Liang J; Wei L; Chen X; Ye X; He J
Expert Opin Drug Saf; 2022 Aug; 21(8):1127-1133. PubMed ID: 35196201
[TBL] [Abstract][Full Text] [Related]
9. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
10. Poor reporting and documentation in drug-associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - Lessons for medication safety.
Goldblatt C; Khumra S; Booth J; Urbancic K; Grayson ML; Trubiano JA
Br J Clin Pharmacol; 2017 Feb; 83(2):224-226. PubMed ID: 27558920
[No Abstract] [Full Text] [Related]
11. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
[TBL] [Abstract][Full Text] [Related]
12. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.
Papay J; Yuen N; Powell G; Mockenhaupt M; Bogenrieder T
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):289-96. PubMed ID: 22139991
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013.
Abe J; Mataki K; Umetsu R; Ueda N; Kato Y; Nakayama Y; Kinosada Y; Hara H; Inagaki N; Nakamura M
Allergol Int; 2015 Jul; 64(3):277-9. PubMed ID: 26117261
[No Abstract] [Full Text] [Related]
16. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
[TBL] [Abstract][Full Text] [Related]
18. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.
Noseda R; Bedussi F; Gobbi C; Zecca C; Ceschi A
Cephalalgia; 2021 Jun; 41(7):789-798. PubMed ID: 33435709
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study.
Rodríguez-Martín S; Martín-Merino E; Lerma V; Rodríguez-Miguel A; González O; González-Herrada C; Ramírez E; Bellón T; de Abajo FJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):237-246. PubMed ID: 30298362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]